PLAT and stroke disorder: Tissue plasminogen activator (TPA) is the only therapeutic approved by the U.S. Food and Drug Administration (FDA), but it must be received within 4.5 h after stroke for the effectiveness,212 and TPA may cause a more serious cerebral hemorrhage.